Vericel (VCEL) Net Cash Flow (QoQ) (2010 - 2026)
Vericel (VCEL) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,059.16% |
| Dec 31, 2025 | -101.57% |
| Sep 30, 2025 | 2,302.78% |
| Jun 30, 2025 | 115.48% |
| Mar 31, 2025 | -136.36% |
| Dec 31, 2024 | 367.06% |
| Sep 30, 2024 | -207.67% |
| Jun 30, 2024 | 131.70% |
| Mar 31, 2024 | -587.87% |
| Dec 31, 2023 | -74.07% |
| Sep 30, 2023 | 41.87% |
| Jun 30, 2023 | -16.57% |
| Mar 31, 2023 | 176.10% |
| Dec 31, 2022 | -575.12% |
| Sep 30, 2022 | 653.92% |
| Jun 30, 2022 | 105.90% |
| Mar 31, 2022 | -148.62% |
| Dec 31, 2021 | 393.45% |
| Sep 30, 2021 | 143.67% |
| Jun 30, 2021 | -126.06% |